Details

Cost-Effectiveness of Palivizumab Prophylaxis for Respiratory Syncytial Virus (RSV): A Systematic Review - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T19:07:27.597Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/cost-effectiveness-palivizumab-prophylaxis-respiratory-syncitial-virus.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-1/20250418190727/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/cost-effectiveness-palivizumab-prophylaxis-respiratory-syncitial-virus.html?wbdisable=false#ha_snapshot=230934
ID: 230934
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots